FDA Approved: TRIUMEQ PD — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approves a supplemental application for TRIUMEQ PD, the fixed-dose combination of abacavir sulfate, dolutegravir sodium, and lamivudine, from ViiV Healthcar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• TRIUMEQ PD (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE)

Snippet

SUPPL AP for TRIUMEQ PD (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE)